drugset / Trial / NCT04033861

Early rhBNP on Myocardial Remodeling and Reperfusion in Patients With STEMI

NCT04033861 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The study intends to evaluate the efficacy of early rhBNP on myocardial remodeling and reperfusion in patients with ST-segment elevation myocardial infarction after percutaneous coronary intervention

Timeline

Start
2019-06-19
Primary completion
2020-08-01
Completion
2023-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject rhBNP Peptide 0.0075 ug/kg Other
Subject rhBNP Peptide 0.01 ug/kg Other